MedTrace Logo

Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye

NCT01089985 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2012-01-18

No results posted yet for this study

Summary

The purpose of this study is to examine the efficacy and safety of autologous serum eye drops in people with recalcitrant dry eye.

Conditions

  • Xerophthalmia

Interventions

DRUG

Autologous serum eyedrops

3 times a day for the duration of the study

Sponsors & Collaborators

  • Singapore National Eye Centre

    lead OTHER_GOV

Principal Investigators

  • Louis Tong, FRCS, MD · Singapore National Eye Centre

  • Ronald Chung · Singapore National Eye Centre

  • Roger Beuerman · Singapore Eye Research Institute

  • Mickey Koh · Singapore General Hospital

  • Samanthila Waduthantri · Singapore National Eye Centre

  • Heng Joo Ng · Singapore General Hospital

  • Rohani Salleh · Singapore General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01089985 on ClinicalTrials.gov